Peer-influenced content. Sources you trust. No registration required. This is HCN.

Journal of Neurology, Neurosurgery & PsychiatryLevetiracetam vs. Fosphenytoin as a Second-line Treatment After Diazepam for Adult Convulsive Status Epilepticus: A Multicenter Non-inferiority Randomized Control Trial

In this multicenter study, adult patients with status epilepticus were randomized into levetiracetam (LEV) or fosphenytoin (FPHT) as a second-line treatment after diazepam. The authors conclude that LEV may be recommended as a second-line treatment for SE along with phenytoin/FPHT.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form